CVD Part 2 Flashcards

1
Q

What is afib?

A

Abnormal electrical conduction in the atria -> chaotic, uncoordinated contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the symptoms of afib (if not asymptomatic)? (4)

A
  1. Shortness of breath, fatigue
  2. Palpitations
  3. Chest discomfort
  4. Anxiety, sweating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are two key clinical issues with afib?

A
  1. Significant ↑ risk of ischemic stroke (~5x)
    - ANTICOAGULATION
  2. ↑ Heart rate -> heart failure
    - Need to control heart rate or rhythm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Manage stroke risk with? (2)

A
  1. Warfarin
  2. DOACs (dabigatran, rivaroxaban, apixaban, edoxaban)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Advanced age is a deterrent to anticoagulation, why? (3)

A
  1. Bleed risk
    - Falls
    - Drugs
    - Medical conditions
  2. Adherence, INR monitoring
    - Cognitive impairment
    - Limited mobility
  3. Underestimation of benefit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does the evidence for anticoagulation in older adults say?

A

Very good for stroke prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What to know about anticoagulation vs. ASA or ASA + Clopidogrel (2)

A
  1. ACTIVE-W Trial
    - Aspirin + Clopidogrel vs Warfarin for stroke prevention in atrial fibrillation
    - Trial terminated early due to superiority of warfarin (NNT = 47/1.3 years)
    - NO difference in major bleeding rates between the two groups
  2. ACTIVE-A Trial
    - Aspirin vs aspirin plus clopidogrel in individuals unsuitable for warfarin
    - Aspirin plus clopidogrel decreased the risk of stroke (NNT = 42/2.6 years)
    - Also increased the risk of major bleeding (NNH = 42/2.6 years)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the advantages of DOACs? (4)

A
  1. > = Efficacy
  2. Less ICH
  3. No INR monitoring
  4. Fewer drug and food interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the disadvantages of DOACs? (6)

A
  1. Cost, EDS requirements?
  2. More GI bleeds
  3. Less long-term safety data
  4. Caution in renal impairment
  5. Contraindicated in severe renal impairment
  6. Not indicated with mechanical heart valves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Consider changing from warfarin to a DOAC when? (4)

A
  1. When starting on a medication with a significant DI with warfarin
  2. Practical considerations - can the pt get their blood work done as often as they need to?
  3. Basically all of the pros that we have talked about.
  4. Labile INRs - if you have someone with afib who has difficulty controlling INR, they should really be switched to a DOAC. Efficacy of warfarin drops dramatically below 2, and is doing basically nothing under 1.8 for stroke risk reduction. Bleed risk is big if above 3. So if consistently not within bounds then it’s a bitch to work with.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Warfarin is preferable when? (2)

A
  1. Severe renal dysfunction. Generally a CrCl <25, for sure CrCl <15 is when you would want to be on warfarin.
  2. Mechanical heart valves. DOACs not as effective in preventing strokes in these settings. Specifically, with a mechanical mitral heart valve, remember that’s when you need to target 2.5-3.5 INR and they need to be on aspirin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which DOAC to choose between dabigatran, rivaroxaban, edoxaban, and apixaban?

A
  1. Dabigatran – most GI upset, most highly renally eliminated
    - Beer’s List drug if age > 75
  2. Rivaroxaban once daily dosing -> needs to be taken with food
    - Beer’s List drug if age > 75
  3. Edoxaban once daily dosing
    - Watch for drug interactions (↓ dose with strong P-GP inhibitors e.g. erythromycin, cyclosporine, dronaderone)
  4. Apixaban best safety data (so far)
    - Best choice when renal function is borderline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 4 considerations for anticoagulation in afib?

A
  1. Is there an indication for anticoagulation?
  2. Is there a high risk of bleeding or a contraindication to anticoagulation?
  3. Will the patient be able to adhere to therapy or monitoring requirements?
  4. Patient/family preferences?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

According to the afib guidelines, what age patient is indicated for oral anticoagulation?

A

65+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HAS-BLED is a score to determine if there is a high risk of bleeding. What is it?

A

Hypertension
Abnormal renal or liver function
Stroke (caused by a bleed)
Bleeding
Labile INRs
Elderly (65+)
Drugs (ASA/NSAID) or alcohol (8+ drinks/week)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Caution if HAS-BLED score is >=_

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When might we do anticoagulant + antiplatelet (3)

A
  1. Elective PCI without high risk features for thrombotic CV events
  2. ACS with PCI or elective PCI with high risk features for thrombotic CV events
  3. ACS without PCI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Will patients be able to adhere to the monitoring requirements of warfarin or DOACs? What to know?

A
  1. Warfarin:
    - INR monitoring
    - Ability to self-manage dosage adjustments?
  2. DOACs:
    - Consistent adherence is very important!
    - Also need to check CBC, renal function ~q6months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are factors to consider when deciding between rate vs. rhythm control? (3)

A
  1. Duration of afib
  2. Bothersome afib symptoms?
  3. Comorbid HF?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the main medication for rhythm control in afib?

A

Amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Likelihood of successful rhythm control _________ as afib duration increases

A

decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

True or False? Regardless of rate or rhythm control, anticoagulation remains important

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the adverse effects of amiodarone? (5)

A
  1. Optic neuropathy and neuritis
  2. Pulmonary and hepatic toxicity
  3. Hypo- or hyper-thyroidism
  4. Blue-grey skin discoloration
  5. Photosensitivity
24
Q

What are the DIs of amiodarone? (4)

A
  1. Warfarin
  2. Digoxin
  3. Beta-blockers
  4. Non-DHP CCBs
25
What are the medications for rate control in afib? (4)
1. Beta-blockers 2. Non-DHP CCBs (diltiazem and verapamil) Second-line 3. Digoxin (additive therapy) 4. Amiodarone
26
When might beta-blockers be the preferred medication for afib rate control?
Preferred when concurrent CAD and HF
27
When might non-DHP CCBs be the preferred medication for afib rate control?
May be preferred in severe or poorly controlled asthma/COPD
28
When might digoxin be used for afib rate control? (4)
1. Less effective – does not control heart rate during exercise 2. Usually used as add-on therapy 3. May be beneficial if concurrent symptomatic HF 4. AFFIRM trial - ↑ mortality when digoxin used for AFib
29
What is target heart rate for afib pt in older adult?
< 100 bpm at rest
30
What should be monitored if pt is on digoxin for afib? (2)
1. Monitoring for efficacy: Target HR - Serum digoxin levels are not a “target” to aim for but a tool to avoid toxicity! 2. Monitoring for toxicity: - Serum levels if concerned about adverse effects/toxicity, drug interactions, or if renal function ↓ - Digoxin adverse effects: Nausea, ↓appetite, vomiting, diarrhea, dizziness, confusion/delirium, blurred vision, “halos” - Older adults much more susceptible to digoxin toxicity - Ideally, maintain trough level < 1 nmol/L - SHA reports “in-range” if 1.3-2.6nmol/L!
31
What are the 4 pillars of HFrEF medications?
1. ARNI (or ACEi/ARB) 2. Beta-blocker 3. MRA 4. SGLT2i
32
Medications for HFrEF: What to initiate and when?
Currently no consensus regarding which drug classes to start with when initiating treatment for HFrEF - Start with one drug class and titrate up to max tolerated dose? - Start with more than one drug class at smaller doses?
33
Medications for HFrEF: Decisions should be based on clinical characterstics of the patient. Such as? (5)
1. Hemodynamic status 2. Renal function 3. Side effects/tolerability 4. Cost 5. Adherence
34
What to know about switching from ACEi to ARNI?
Requires a 36-hour washout period
35
What are some considerations for ACEi/ARB/ARNIs in HFrEF? (3)
1. Monitor SCr, lytes within 1-2 weeks of initiation or titration - < 30% ↑in SCr 2. Monitor sitting and standing BP - Orthostatic hypotension may warrant dose ↓ - Use lowest required dose of diuretic 3. ARNI (valsartan/sacubitril) - Accumulating evidence for initiating directly in new diagnoses of HFrEF in hospitalized patients -- Currently, EDS in SK requires patients to be on a stable dose of ACEI or ARB for > 4 weeks before initiating - Frail older adults more susceptible to hypotension/orthostatic hypotension with ARNI vs. ACEI or ARB alone
36
What to monitor in pt using a beta-blocker? (2)
1. Heart rate 2. Blood pressure
37
What to monitor in pt using an MRA? When to avoid?
1. Potassium 2. BEERS critera: avoid if CrCl < 30 mL/min
38
What to monitor in pt using SGLT2i? (2)
1. Decreased eGFR ~15% on initiation 2. Volume status - may need to decrease diuretic dose on initiation in euvolemic pts
39
What is the initiation regimen of SGLT2is for HFrEF? (2)
1. Dapagliflozin 10 mg daily (eGFR > 30 ml/min) 2. Empagliflozin 10 mg daily (eGFR > 20 ml/min)
40
What are 2 precautions for SGLT2is?
1. ↓ BP ~1-2mmHg 2. “Sick-day” medication
41
What are 3 tolerability considerations for SGLT2is?
1. Increased risk of genital fungal infections 2. ? increased UTIs 3. ? increased DKA
42
When to use loop diuretic in HF?
Symptomatic treatment - Used to manage SOB, fluid retention, increased weight
43
When might digoxin be used in HFrEF? (4)
1. Add-on if symptoms persist despite optimized 1st and 2nd line meds - May also help ↓ resting HR in AFib 2. 0.0625 – 0.125 mg daily 3. Signs of toxicity: Nausea, vomiting, diarrhea, delirium, drowsiness, headache, vision changes (yellow or green halos, photophobia) 4. Blood levels are not a target but a tool to avoid toxicity! - Levels < 1nmol/L associated with ↓ mortality, hospitalizations - Levels > 1.5 nmol/L associated with ↑ mortality - Note: Therapeutic range for digoxin in SHA reported to be between 1.3-2.6 nmol/L
44
Treatment for HFpEF?
Perhaps empagliflozin
45
What are some risk factors for acquired TdP? (8)
1. ↑ age 2. Female 3. Electrolyte abnormalities: Hypokalemia, hypocalcemia, hypomagesemia 4. Liver or kidney disease 5. Hypertension 6. Smoking 7. Arrhythmia, previous MI, cardiomyopathy 8. DRUGS
46
What antiarrhythmics can prolong QT interval? (3)
1. Amiodarone 2. Sotalol 3. Propafenone, procainamide, flecainide, others
47
What ADHD meds can prolong QT interval? (1)
Atomoxetine
48
What antiemetic drug can prolong QT interval? (1)
Domperidone
49
What antipsychotics can prolong QT interval? (5)
1. Aripiprazole 2. Haloperidol 3. Pimozide 4. Quetiapine > risperidone 5. Clozapine
50
What SSRIs can prolong QT interval? (3)
1. Sertraline 2. Citalopram 3. Escitalopram
51
What SNRIs can prolong QT interval?
Mirtazapine > venlafaxine
52
What TCAs can prolong QT interval?
All > nortriptyline
53
What antibiotics can prolong QT interval?
1. Moxi- /gatifloxacin > ciprofloxacin or levofloxacin 2. Clarithro/erythromycin > azithromycin
54
What antifungals can prolong QT interval?
Fluconazole > others
55
What misc drugs can prolong QT interval? (4)
1. Donepezil 2. Hydroxyzine 3. Methadone 4. Tramadol